Home > Insider Trading > Filing (0001415889-22-002868)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1708527	Aziyo Biologics Inc.	AZYO	Biological Products, (No Disgnostic Substances) (2836)	474790334

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1825799	Thomas Englese	C/O Aziyo Biologics, Inc. 12510 Prosperity Drive, Suite 370 Silver Spring MD 20904	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2022-03-08	938	$0.00	6,883	No	4	M	Direct
Class A Common Stock	Disposition	2022-03-10	276	$0.00	6,607	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy)	Acquisiton	2022-03-08	31,000	$0.00	31,000	$5.08
Class A Common Stock	Restricted Stock Units	Acquisiton	2022-03-08	8,700	$0.00	8,700	$0.00
Class A Common Stock	Restricted Stock Units	Disposition	2022-03-08	938	$0.00	938	$0.00
Class A Common Stock	Restricted Stock Units	Acquisiton	2022-03-08	15,390	$0.00	15,390	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,000	2032-03-08	No	4	A	Direct
8,700		No	4	A	Direct
2,812		No	4	M	Direct
15,390		No	4	A	Direct

Footnotes

Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis.
Includes 857 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.16 to $5.34. The Reporting Person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026.
Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024.
On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning in March 8, 2022.
The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.